Cryoviva Life Sciences conducted a very informative and interactive session on stem cell banking and predictive health planning during a recent baby shower event which aims at helping expecting parents to understand that how medical science today is enabling more proactive and future ready decision related to healthcare from the time of birth.

The session mainly focussed on the long term health values of cord blood and cord tissue stem cell preservation explaining that how these stem cells can provide lifelong access to those resources which are biologically valuable and support treatment for over 90 approved blood, immune and metabolic disorders, while also holding potentials across hundreds of emerging applications currently working under clinical research in regenerative and personalised medicine as well.

Commenting on the session, Dr. Aditi Kundoo, Medical Director, Cryoviva Life Sciences, India, said, “Stem cell banking is no longer a concept which is limited to the future it is a scientifically backed healthcare decision available to parents today. With core blood already being used in the treatment of many diseases and cord tissue stem cells showing vast potential in regenerative medicine, preserving these cells at birth offers families a unique form of biological security. Our main focus is to empower parents with clear, information based on evidence so that they can make a confident and informed choices for the long term health of their child”.

Experts from Cyroviva explained that stem cells possess natural ability to repair, regenerate and restore the tissues which are damaged, making them increasingly relevant as lifestyle and chronic disease increases. A key message highlighted during the session was that collection of stem cell is one time opportunity that can only be done at the birth, making early awareness and timely decision making critical for the patients.

The session also highlighted that how stem cell banking aligns with the evolving landscape of predictive and preventive healthcare, offering potential benefits not only to child but also for the sibling, family member, subject to genetic compatibility. Parents were informed about the safe, painless, and risk-free collection process as well as the long term piece of mind that comes with this one time medical investment.

As a leading healthcare vertical of RJ Corp, Cryoviva Life Sciences continue to play a significant role in making preservation of stem cell and predictive genomics accessible to families across India through the modernised infrastructure, medical expertise and science led counselling.

The session ended with an interactive discussion, real time medical examples and guidance led by experts helping expecting parents navigate myths, understand the benefits and make well informed decisions before delivery.